Medical Hypotheses
Volume 57, Issue 1 , Pages 51-55 , July 2001

Hunting genes in Parkinson’s disease from the roots

  • U. Muthane

      Affiliations

    • Department of Neurology, Molecular Genetics Laboratory
    • ,
  • S. Jain

      Affiliations

    • Department of Psychiatry and
    • ,
  • G. Gururaj

      Affiliations

    • Department of Epidemiology, National Institute of Mental Health and Neurosciences, Bangalore, India

Received 1 August 2000 ,Accepted 9 January 2001.

References 

    REFERENCES
  1. Polymeropoulos MH, Higgins JJ, Golbe LI. Mapping of a gene for Parkinson’s disease to chromosome 4q21–q23. Science. 1996;274:1197–1199
  2. Kitada T, Asakawa S, Matsumine H. Mutations in the parkin gene cause autosomal recessive juvenile parkinsonism. Nature. 1998;392:605–608
  3. Gasser T, Muller-Myhsok B, Wszolek ZK. Genetic heterogeneity in familial parkinsonism: no linkage to the PD-1 locus on chromosome 4q in 11 of 13 families. Science. 1997;;276:2045–2047
  4. Polymeropoulos MH, Lavedan C, Leroy E. Mutation in the alpha-synuclein gene identified in families with Parkinson’s disease. Science. 1997;276:2045–2047
  5. Marder K, Tang M-X, Mejia H. Risk of Parkinson’s disease among first-degree relatives: A community-based study. Neurology. 1996;47:155–160
  6. Elbaz F, Grigoletto F, Baldereschi M. Familial aggregation of Parkinson’s disease: a population based case-control study in Europe. EUROPARKINSON study Group. Neurology. 1999;52:1876–1882
  7. Wang M, Hattori N, Kobayashi T. Polymorphisms in the parkin gene in sporadic Parkinson’s disease. Ann Neurol. 1999;45:655–658
  8. Tanner CM, Marsden CD, Fahn S. Movement Disorders Vol. 3. Oxford: Butterworth-Heinemann Ltd;; 1994; p. Epidemiological clues to the cause of Parkinson’s disease
  9. Zhang Z, Roman GC. Worldwide occurrence of Parkinson’s disease: An updated review. Neuroepidemiology. 1993;12:195–208
  10. Ben-Shlomo Y. How far are we in understanding the cause of Parkinson’s disease?. J Neurol Neurosurg Psychiatry. 1996;61:4–16
  11. Muthane U, Yasha TC, Shankar SK. Low Numbers and No Loss of Melanized Nigral Neurons with Increasing Age in Normal Human Brains from India. Ann Neurol. 1998;43:283–287
  12. Wadia NH, Bhatia K. Multiple Sclerosis is prevalent in the Zoroastrians (Parsis) of India. Ann Neurol. 1990;28:177–179
  13. Schoenberg BS, Osuntokun BO, Adeuja AOG, Bademosi O, Nottidge V, Anderson DW. Comparison of the prevalence of Parkinson’s disease in black populations in the rural United States and in rural Nigeria: Door-to-door community studies. Neurology. 1988;38:645–646
  14. Halushka MK, Fan JB, Bentley K. Patterns of single-nucleotide polymorphisms in candidate genes for blood-pressure homeostasis. Nat Genet. 1999;22:239–247
  15. Cavalli-Sforza LL. The DNA revolution in population genetics. TIG. 1998;14:60–65
  16. Gelernter J, Kranzler H, Lacobelle J. Population studies of polymorphisms at loci of neuropsychiatric interest Tryptophan hydroxylase (TPH), Dopamine transporter protein (SLC6A3), D3 dopamine receptor (DRD3), Apolipoprotrin E (APOE), μ opiod receptor (OPRM1), and Ciliary neurotrophic factor (CNTF). Genomics. 1999;52:289–297
  17. Jain S, Leggo J, DeLisi LE. Analysis of thirteen trinucleotide repeat loci as candidate genes for schizophrenia and bipolar affective disorder. Am J Med Genet. 1996;67:139–146
  18. Saleem Q, Vijaykumar M, Mutsuddi M, Chowdhary N, Jain S. Variation at the MJD locus in the major psychoses. Am J Med Genet (Neuropsychiatric Genetics. 1998;67:139–146
  19. Kruger R, Vieira-Saecker AM, Kuhn W, Berg D, Muller T, Kuhnl N, et al. Increased susceptibility to sporadic Parkinson’s disease by a certain combined alpha-synuclein/apolipoprotein E genotype. Ann Neurol. 1999;45:611–617
  20. Hirsch EC, Graybiel AM, Agid Y. Melanized dopaminergic neurons are differentially affected in Parkinson’s disease. Nature. 1988;334:345–348
  21. Fearnley JM, Lees AJ. Ageing and Parkinson’s disease: Substantia nigra regional activity. Brain. 1991;114:2283–2301
  22. Ben-Shlomo Y, Wenning GK. Incidental Lewy body disease in black Africans. Lancet. 1994;344:882–883
  23. Heikkila RE, Sieber BA, Manzino L, Sonsalla PK. Some features of the nigrostriatal dopaminergic neurotoxicity of 1-methyl-1,2,3,6-tetrahydropyridine (MPTP) in the mouse. Mol Chem Neuropathol. 1989;101:171–183
  24. Sonsalla PK, Heikkila RE. The influence of dose and dosing interval in MPTP-induced dopaminergic neurotoxicity. Eur J Pharmacol. 1986;129:339–345
  25. Muthane U, Ramsay KA, Jiang H. Difference in Nigral neuron number and sensitivity to 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine in C57/b1 and CD-1 mice. Experimental Neurology. 1994;126:195–204
  26. Riachi NJ, Harik SI. Strain differences in systemic 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine neurotoxicity in mice correlate best with monoamine oxidase activity at the blood-brain barrier. Life Sciences. 1988;42:2359–2362
  27. Przedborski S, Jackson-Lewis V, Kostic V, Carlson E, Epstein CJ, Cadet JL. Superoxide dismutase, Catalase and Glutathione peroxidase activities in Copper/zinc-superoxide dismutase transgenic mice. J Neurochem. 1992;58:1760–1767
  28. Undevia JV, Balakrishnan V, Verma IC. Medical Genetics in India Vol.2. Pondicherry: Auroma Enterprises;; 1978;
  29. Radharama-Devi A, Rao NA, Bittles AH. Inbreeding in the state of Karnataka, South India. Hum Heredity. 1962;32:8–10
  30. Harik SI, Riachi NJ, Kalaria RN, Johansson BB, Owman Ch, Widner H. The role of the blood-brain barrier in preventing MPTP neurotoxicity. Pathophysiology of the blood-brain barrier. Amsterdam: Elsvier Science Publishers (Biomedical Division);; 1990;
  31. Chakravarti A. Population genetics- making sense out of sequence. Nature. 1999;21:56–60
  32. Wright AF, Carothers AD, Pirastu M. Population choice in mapping genes for complex disorders. Nature (Genetics). 1999;23:397–404
  33. Nicklas BJ, Ferrell RE, Rogus EM. Lipoprotein lipase gene variation is associated with adipose tissue lipoprotein lipase activity, and lipoprotein lipid and glucose concentrations in overweight postmenopausal women. HumanGenetics. 2000;106:420–424
  34. Hall S, Talmud PJ, Cook DG. Frequency and allelic association of common variants in the lipoprotein lipase gene in different ethnic groups: The Wandsworth Heart and Stroke Study. Genetic Epidemiology. 2000;18:203–216
  35. Markopoulou K, Langston JW. Candidate genes and Parkinson’s disease: Where to next?. Neurology. 1999;53:1382–1383
  36. Nicholl DJ, Bennett P, Hiller L. A study of five candidate genes in Parkinson’s disease and related neurodegenerative disorders. Neurology. 1999;53:1415–1421
  37. Cargill M, Altshuler D, Ireland J. Characterization of single-nucleotide polymorphisms in coding regions of human genes. Nat Genet. 1999;22:231–238
  38. Razdan S, Kaul RL, Motta A, Kaul S, Bhatt RK. Epidemiology of Neurological disorders in Kashmir. Neuroepidemiology. 1994;13:113–119
  39. Gourie-Devi M, Satishchandra P. Bangalore Urban and Rural Neurological Survey. [Report] Indian Council of Medical Research. 1995;
  40. Das SK, Sanyal K. Neuroepidemiology of major neurological disorders in rural Bengal. Neurology India. 1996;44:47–58
  41. Bharucha NE, Bharucha EP, Bharucha AE, Bhise AV, Schoenberg BS. Prevalence of Parkinson’s disease in the Parsi community of Bombay, India. Arch Neurol. 1998;45:1321–1323
  42. Ashok PP, Radhakrishna K, Sridharan R, Mousa ME. Epidemiology of Parkinson’s Disease in Benghazi. Clin Neurol Neurosurg. 1986;88:109–113
  43. al Rajeh S, Bademosi O, Ismail H. A community survey of neurological disorders in Saudi Arabia: The Thugbah study. Neuroepidemiology. 1993;12:164–178
  44. Okada K, Kobayashi S, Tsunematsu T. Prevalence of Parkinson’s Disease in Izumo City. Gerontology. 1990;36:340–344
  45. Schoenberg BS, Anderson DW, Haerer AF. Prevalence of Parkinson’s disease in the biracial population of Copiah County, Mississipi. Neurology. 1985;35:841–845
  46. Mayeux R, Marder K, Cote LJ. The frequency of idiopathic Parkinson’s disease by age, ethnic group, and sex in northern Manhattan, 1988–1993. Am J Epidemiol. 1995;142:820–8277
  47. Morgante L, Rocca WA, Di Rosa AE. Prevalence of Parkinson’s disease and other types of parkinsonism: a door-to-door survey in three Sicilian municipalities. The Sicilian Neuro-Epidemiologic Study (SNES) Group. Neurology. 1992;42:1901–1907
  48. Casetta I, Granieri E, Govoni V, Tola MR, Paolino E, Monetti VC, et al. Epidemiology of Parkinson’s disease in Italy. A descriptive survey in the U.S.L. of Cento, province of Ferrara, Emilia-Romagna. Acta Neurol Scand. 1990;12:284–291

PII: S0306-9877(01)91289-7

doi: 10.1054/mehy.2001.1289

Medical Hypotheses
Volume 57, Issue 1 , Pages 51-55 , July 2001

Article Tools